Effects of inhalable microparticles of seonpyejeongcheon-tang in an asthma mouse model- Effects of microparticles of SJT

Journal of Pharmacopuncture

Volumn 19, Issue 4, 2016, Pages 303-311

  Yang, Won Kyung ^a   Lee, Chul Hwa ^a   Kim, Min Hee ^a   Kim, Seung Hyeong ^a   Choi, Hae Yoon ^b   Yeo, Yoon ^c,d   Park, Yang Chun ^a  

^a Daejeon University   (South Korea)

^b Daegu Haany University   (South Korea)

^c PURDUE UNIVERSITY   (United States)

^d PURDUE UNIVERSITY   (United States)

Author keywords

Asthma; Cigarette smoking; Inhalable microparticles; Seon pyejeongcheon tang (SJT); Spray drying

Indexed keywords

EID: 85019858476     PISSN: 20936966     EISSN: 22346856     Source Type: Journal    
DOI: 10.3831/KPI.2016.19.031     Document Type: Article

References (28)

1. Kay AB. Asthma and inflammation. J Allergy Clin Immunol. 1991;87(5):893-910.
2. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma. from bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med. 2000;161(5):1720-45.
3. Barrett NA, Austen KF. Innate cells and T helper 2 cell immunity in airway inflammation. Immunity. 2009;31(3):425-37.
4. Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, et al. Eosinophilic inflammation in asthma. N Engl J Med. 1990;323(15):1033-9.
5. Walker C, Kaegi MK, Braun P, Blaser K. Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J Allergy Clin Immunol. 1991;88(6):935-42.
6. Caramori G, Pandit A, Papi A. Is there a difference between chronic airway inflammation in chronic severe asthma and chronic obstructive pulmonary disease?. Curr Opin Allergy Clin Immunol. 2005;5(1):77-83.
7. Tillie-Leblond I, Gosset P, Tonnel AB. Inflammatory events in severe acute asthma. Allergy. 2005;60(1):23-9.
8. Kao ST, Chang CH, Chen YS, Chiang SY, Lin JG. Effects of Ding-Chuan-Tang on bronchoconstriction and airway leucocyte infiltration in sensitized guinea pigs. Immunopharmacol Immunotoxicol. 2004;26(1):113-24.
9. Chan CK, Kuo ML, Shen JJ, See LC, Chang HH, Huang JL. Ding Chuan Tang, a Chinese herb decoction, could improve airway hyper-responsiveness in stabilized asthmatic children: a randomized, double-blind clinical trial. Pediatr Allergy Immunol. 2006;17(5):316-22.
10. Yoon JM, Park YC. [Protective effects of Seonpyejeongcheon-tang on elastase-induced lung injury in mice]. Kor Journal Orient Int Med. 2010;31(1):84-101. Korean.
11. Park YC. [A retrospective review of the effectiveness of Seonpyejeongcheon-tang on chronic cough]. Journal of Korean Medicine Institute of Daejeon University. 2012;20(2):111-6. Korean.
12. KMFDS. [List of investigational new drug (2012.01.01~2012.12.31)]. Chungbuk: KMDFS; 2012.
13. Park YC, Jin M, Kim SH, Kim MH, Namgung U, Yeo Y. Effects of inhalable microparticle of flower of Lonicera japonica in a mouse model of COPD. J Ethnopharmacol. 2014;151(1):123-30.
14. Ibrahim BM, Jun SW, Lee MY, Kang SH, Yeo Y. Development of inhalable dry powder formulation of basic fibroblast growth factor. Int J Pharm. 2010;385(1-2):66-72.
15. Yang Y, Bajaj N, Xu P, Ohn K, Tsifansky MD, Yeo Y. Development of highly porous large PLGA microparticles for pulmonary drug delivery. Biomaterials. 2009;30(10):1947-53.
16. Kim SH, Kim BK, Lee YC. Antiasthmatic effects of hesperidin, a potential Th2 cytokine antagonist, in a mouse model of allergic asthma. Mediators Inflamm. 2011;2011:DOI: 10.1155/2011/485402.
17. Duret C, Wauthoz N, Merlos R, Goole J, Maris C, Roland I, et al. In vitro and in vivo evaluation of a dry powder endotracheal insufflator device for use in dose-dependent preclinical studies in mice. Eur J Pharm Biopharm. 2012;81(3):627-34.
18. Liu C, Yang N, Song Y, Wang L, Zi J, Zhang S, et al. Ganoderic acid C1 isolated from the anti-asthma formula, ASHMI suppresses TNF-alpha production by mouse macrophages and peripheral blood mononuclear cells from asthma patients. Int Immunopharmacol. 2015;27(2):224-31.
19. Choi HJ, Bang NY, Song BW, Kim NJ, Rhyu BH. [Survey on the preference for the dosage forms of oriental herbal medicine]. J Kyung Hee Uni Med Cent. 2004;20(1):46-57. Korean.
20. Derendorf H, Nave R, Drollmann A, Cerasoli F, Wurst W. Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma. Eur Respir J. 2006;28(5):1042-50.
21. Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol. 2008;8(3):183-92.
22. Epstein MM. Targeting memory Th2 cells for the treatment of allergic asthma. Pharmacol Ther. 2006;109(1-2):107-36.
23. Tomkinson A, Duez C, Cieslewicz G, Pratt JC, Joetham A, Shanafelt MC, et al. A murine IL-4 receptor antagonist that inhibits IL-4- and IL-13-induced responses prevents antigen-induced airway eosinophilia and airway hyperresponsiveness. J Immunol. 2001;166(9):5792-800.
24. McKinnon M, Page K, Uings IJ, Banks M, Fattah D, Proudfoot AE, et al. An interleukin 5 mutant distinguishes between two functional responses in human eosinophils. J Exp Med. 1997;186(1):121-9.
25. Sanderson CJ. Interleukin-5, eosinophils, and disease. Blood. 1992;79(12):3101-9.
26. MacLean JA, Ownbey R, Luster AD. T cell-dependent regulation of eotaxin in antigen-induced pulmonary eosinophila. J Exp Med. 1996;184(4):1461-9.
27. Yang Y, Tsifansky MD, Wu CJ, Yang HI, Schmidt G, Yeo Y. Inhalable antibiotic delivery using a dry powder co-delivering recombinant deoxyribonuclease and ciprofloxacin for treatment of cystic fibrosis. Pharm Res. 2010;27(1):151-60.
28. Ben-Jebria A, Chen D, Eskew ML, Vanbever R, Langer R, Edwards DA. Large porous particles for sustained protection from carbachol-induced bronchoconstriction in guinea pigs. Pharm Res. 1999;16(4):555-61.